RADT-45. THE MULTICENTER SOPRANO STUDY: OUTCOMES OF PATIENTS WITH IDH-MUTATED WHO GRADE 2 AND 3 GLIOMA TREATED WITH PROTON OR PHOTON RADIOTHERAPY
Sign Up to like & getrecommendations! Published in 2025 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaf201.0414
Abstract: Concerns were raised about an observed increase in treatment-related effects in patients treated with proton radiotherapy for glioma. This study compares next-intervention free survival in IDH-mutated WHO grade 2 and 3 glioma patients treated with… read more here.
Keywords: idh mutated; grade glioma; radiotherapy; photon radiotherapy ... See more keywords
Diagnostic Utility of Oncomine Comprehensive Assay v3 in Differentiating Between Isocitrate Dehydrogenase (IDH)-mutated Grade II-III Astrocytoma and Oligodendroglioma
Sign Up to like & getrecommendations! Published in 2021 at "In Vivo"
DOI: 10.21873/invivo.12332
Abstract: Background/Aim: The application of Oncomine Comprehensive Assay v3 (OCAv3) panel in diffuse gliomas (DGs) remains unknown. We investigated the utility of OCAv3-based next-generation sequencing (NGS) in isocitrate dehydrogenase (IDH)-mutated grade II-III DGs. Patients and Methods:… read more here.
Keywords: grade iii; comprehensive assay; mutated grade; idh mutated ... See more keywords